Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04818242 · ClinicalTrials.gov registry record · NA
Dexcom Continuous Glucose Monitoring in Long-term Care
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT04818242 is a NA study that has completed, run by Emory University. The registered enrollment target is 100 participants.
The verdict
NCT04818242, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The goal of this study is to determine whether the use of Dexcom Continuous Glucose Monitoring with Glucose Telemetry System (CGM-GTS) with hypoglycemia alarm will facilitate diabetes treatment and reduce the risk of hypoglycemia in insulin and non-insulin treated patients with type 2 diabetes (T2D) in long-term care facilities, when compared to standard of care using capillary point of care testing.
Interventions
- DEVICE Dexcom G6 CGM with GTS
- DIAGNOSTIC_TEST POC Blood Glucose Test + Blinded CGM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-04-19 |
| Est. Completion | 2022-10-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04818242
The ClinicalTrials.gov registry entry for NCT04818242 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexcom G6 CGM with GTS is the first listed.
NCT04818242 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04818242 about?
NCT04818242 is a clinical study titled "Dexcom Continuous Glucose Monitoring in Long-term Care". The goal of this study is to determine whether the use of Dexcom Continuous Glucose Monitoring with Glucose Telemetry System (CGM-GTS) with hypoglycemia alarm will facilitate diabetes treatment and reduce the risk of hypoglycemia in insulin and non-insulin treated patients with type 2 diabetes (T2D)...
What is the current status of trial NCT04818242?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2021-04-19. Estimated completion is 2022-10-21.
What interventions are being tested in trial NCT04818242?
The interventions under investigation include: Dexcom G6 CGM with GTS (DEVICE), POC Blood Glucose Test + Blinded CGM (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04818242?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.